NCT07235488 Effectiveness of Integrative Medical Treatment in Sudden Hearing Loss
| NCT ID | NCT07235488 |
| Status | Recruiting |
| Phase | — |
| Sponsor | China Medical University Hospital |
| Condition | Sudden Hearing Loss |
| Study Type | INTERVENTIONAL |
| Enrollment | 64 participants |
| Start Date | 2024-07-08 |
| Primary Completion | 2026-05-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 64 participants in total. It began in 2024-07-08 with a primary completion date of 2026-05-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Sudden hearing loss is an emergency in otolaryngology that requires diagnosis and treatment as soon as possible. The golden treatment period is two weeks since the onset of the disease. However, modern medicine is still unable to fully understand the causes of the disease and in lack of corresponding effective treatments. Current therapies also have their own limitations and side effects. To find an effective and safe treatment, integrating with modern medicine and providing inpatient and outpatient medical care, is an important issue in clinical care. Traditional Chinese medicine has been clinically utilized for a long time with accumulated empirical experience and evidence for its efficacy. It can be used as an alternative therapeutic option for sudden hearing loss. Being with a long period of clinical experience and evidence-based curative effect, acupuncture could be applied as an adjunctive treatment for the sudden hearing loss. Currently, this patient-centered, pragmatic clinical trial compares the effectiveness of using west medicine、combination of west medicine and traditional Chinese medicine. The aim of this study is to explore acceptable and beneficial strategy to reduce the clinical symptoms, to improve quality of life, and decrease medical expenses.
Eligibility Criteria
Inclusion Criteria: * Age ≥18 years, both male and female. * Meeting the diagnostic criteria for sudden sensorineural hearing loss (SSNHL), defined as hearing loss of \>30 dB affecting at least three consecutive frequencies within 3 days. * Newly onset of hearing loss within 2 week. * Fully understanding the purpose and procedures of the study and providing signed informed consent. Exclusion Criteria: * Central nervous system lesions such as vestibular schwannoma or traumatic brain injury. * Middle ear or retrocochlear pathology. * History of otologic surgery. * Hemorrhagic disorders or coagulation abnormalities. * Inability to cooperate with examinations due to dementia or psychiatric illness. * Previous treatment for SSNHL on the same affected side within the past 6 months.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07235488 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Sudden Hearing Loss. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07235488 currently recruiting?
Yes, NCT07235488 is actively recruiting participants. Contact the research team at mchuang1128@gmail.com for enrollment information.
Where is the NCT07235488 trial being conducted?
This trial is being conducted at Taichung, Taiwan.
Who is sponsoring the NCT07235488 clinical trial?
NCT07235488 is sponsored by China Medical University Hospital. The trial plans to enroll 64 participants.